Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  ISIS Pharmaceuticals, Inc.    ISIS

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/27/2015 07/28/2015 07/29/2015 07/30/2015 07/31/2015 Date
53.68(c) 54.4(c) 53.05(c) 53.17(c) 54.93(c) Last
2 102 321 1 555 897 1 854 742 1 181 369 1 584 673 Volume
+1.00% +1.34% -2.48% +0.23% +3.31% Change
More quotes
Financials ($)
Sales 2015 298 M
EBIT 2015 -31,8 M
Net income 2015 -35,2 M
Finance 2015 401 M
Yield 2015 -
Sales 2016 318 M
EBIT 2016 -42,4 M
Net income 2016 -78,0 M
Finance 2016 558 M
Yield 2016 -
PER 2015 -
PER 2016
EV / Sales 2015 20,7x
EV / Sales 2016 18,9x
Capitalization 6 576 M
More Financials
Company
Isis Pharmaceuticals, Inc. engages in the development and commercialization of antisense drug discovery platform.It operates through the Drug Discovery and Development segment which exploits a novel drug discovery platform created to generate a broad pipeline of first-in-class drugs for the company... 
More about the company
Surperformance© ratings of ISIS Pharmaceuticals, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ISIS PHARMACEUTICALS, INC.
07/29 ISIS PHARMACEUTICALS : Positive Clinical Data From Lpa Lowering Drug ISIS-APOa R..
07/29 ISIS PHARMACEUTICALS : Positive Clinical Data From Volanesorsen Published in the..
07/29 ISIS PHARMACEUTICALS : Initiates Clinical Study of ISIS-HTT Rx in Patients With ..
07/28 ISIS PHARMACEUTICALS' : Second Quarter 2015 Financial Results Conference Call (W..
07/27 ISIS PHARMACEUTICALS : Reports Data from ISIS-TTR Rx in patients with Transthyre..
07/22 ISIS PHARMACEUTICALS : Earns $2.15M For Advancing ISIS-SMN Rx in Children with S..
07/22 ISIS PHARMACEUTICALS : Positive Clinical Data From Lp(a) Lowering Drug ISIS-APO(..
07/21 ISIS PHARMACEUTICALS : Initiates Clinical Study of ISIS-HTT Rx in Patients With ..
More news
Sector news : Biotechnology & Medical Research - NEC
07/31 QUINTILES TRANSNATIONAL : Announces Pricing of Secondary Public Offering
07/30 SEATTLE GENETICS : reports 2Q loss
07/30 QUINTILES TRANSNATIONAL : Announces Launch of Secondary Public Offering of Commo..
More sector news : Biotechnology & Medical Research - NEC
4-Traders Strategies on ISIS PHARMACEUTICALS, INC. 
2014A resistance as obstacle
More Strategies
News from SeekingAlpha
07/30 PREMARKET BIOTECH DIGEST : Familial Hypercholesterolemia, Dynavax BLA Track, Ear..
07/28 ISIS PHARMACEUTICALS : Another Entry Point
07/28 Buy ConocoPhillips When Oil Is At $43 - Cramer's Lightning Round (7/27/15)
07/27 BIOGEN FALLS HARD : Is It Undervalued Now?
07/20 PREMARKET BIOTECH DIGEST : Alzheimer's Conference, Gilead New ODD, Axovant Pops


Comments 
Advertisement
Chart ISIS PHARMACEUTICALS, INC.
Duration : Period :
ISIS Pharmaceuticals, Inc. Technical Analysis Chart | ISIS | US4643301090 | 4-Traders
Full-screen chart
Technical analysis trends ISIS PHARMACEUTIC...
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions